Skip to content

Understand Fatty Liver Disease

Learn about fatty liver disease, lifestyle evidence, and questions for your care team.

Fatty liver disease linked to metabolic dysfunction is now usually called MASLD. The outcome worth chasing is less liver fat, lower inflammation and fibrosis risk, and better control of the diabetes, weight, lipids, blood pressure, and alcohol exposure that shape long-term liver and heart health. A lower enzyme on one test is a small part of that.

Most people with early MASLD can improve it substantially. The first clinical priority is finding out who already has significant fibrosis, because fibrosis, more than the amount of fat, is the strongest liver-related risk marker. Simple blood-based scores and elastography can help. A normal ALT does not reliably rule fibrosis out.

What to do

  • Lose weight at a pace you can keep if excess weight is a driver. Even modest loss can reduce liver fat; larger, maintained losses are more likely to improve inflammation and fibrosis. The right amount and method are individual.
  • Pick a food pattern you can stay on. A Mediterranean-style pattern rich in vegetables, legumes, whole grains, fish, nuts, and unsaturated oils is a sound default. Cut sugary drinks, excess refined carbohydrate, and the ultra-processed foods you eat on repeat.
  • Move every week. Aerobic and resistance exercise can reduce liver fat even without major weight loss. Start where you are and build toward regular moderate activity plus two strength sessions.
  • Be honest about alcohol. MASLD can coexist with alcohol-related injury. The safest amount depends on liver status and other risks; advanced fibrosis or cirrhosis usually calls for abstinence.
  • Treat diabetes, lipids, and blood pressure. Cardiovascular disease is a major risk for people with MASLD. Evidence-based metabolic treatment is part of liver care.
  • Review medicines and other liver causes. Viral hepatitis, autoimmune disease, iron overload, and some medicines can cause or worsen abnormal liver findings. Don’t assume all the fat or enzyme elevation has one cause.
  • Use disease-directed care when eligible. Some people with more advanced inflammatory disease qualify for medication or specialist care, depending on confirmed stage and current approvals.

A simple plan

Start from the diagnosis and risk stage you actually have: imaging, ALT and AST, platelet count, diabetes status, lipids, blood pressure, alcohol pattern, weight trend, and any fibrosis score or elastography. Ask whether you need hepatology follow-up.

For 12 weeks, run a plan you can repeat: replace sugary drinks, cook two plant-forward dinners a week, walk briskly for 30 minutes on five days, and strength train twice. If weight loss is appropriate, aim for a steady trend, not a crash. Set a clear alcohol limit.

Schedule reassessment around the marker that can answer the question: metabolic labs and weight sooner, liver imaging or fibrosis assessment at a clinically meaningful interval.

How to know it is working

Useful signals: a sustained drop in weight or waist when appropriate, better glucose and triglycerides, improved fitness, lower liver fat on comparable imaging, and improving ALT or AST in context. Fibrosis measures move more slowly and can be noisy. A lower enzyme value is encouraging but does not prove the disease or fibrosis is gone.

What to expect

Liver fat can fall within weeks of an effective energy deficit and regular activity. Inflammation and fibrosis take longer. People respond differently, and you keep the gains only as long as you keep the plan. Even if liver markers change modestly, better blood pressure, diabetes control, fitness, and ApoB can substantially lower the cardiovascular risk that comes with MASLD.

If you get stuck

Check liquid calories, alcohol, weekend patterns, sleep apnea, medication adherence, and whether the plan is too restrictive. If enzymes stay elevated, ask whether another liver condition has been ruled out. When meaningful weight loss or fibrosis risk needs more than self-directed habits, a dietitian, obesity-medicine clinician, diabetes clinician, or hepatologist can help.

A quick note

Don’t use “liver detox” products. Some supplements can injure the liver, and product contents may be uncertain. Advanced fibrosis, cirrhosis, pregnancy, or rapidly changing liver tests need an individualized clinical plan.

Sources

  1. AASLDAASLD: clinical assessment and management of MASLD
  2. American Diabetes AssociationAmerican Diabetes Association: 2026 comprehensive medical evaluation and MASLD assessment
  3. NIDDKNIDDK: metabolic dysfunction-associated steatotic liver disease
View all 31

This guide is educational health information, not medical advice. It is not meant to diagnose, treat, or prevent any disease or condition, and it does not replace advice from your clinician. If you are or may be pregnant, nursing, have a history of an eating disorder, or have another medical condition, talk to your doctor before acting on it.

Created by Murph Health CommonsHow these guides are made